Russian Expert Council identifies **Prospekta** as strongest adjunctive pharmacotherapy for pediatric **ADHD**
[Expert Council resolution: adjunctive pharmacotherapy for hyperkinetic disorders (attention deficit hyperactivity disorder) in children and adolescents].
Abstract
A Russian Expert Council resolution identified Prospekta as having the strongest evidence base for adjunctive pharmacotherapy in pediatric ADHD, based on double-blind randomized controlled trials.
